Methodological considerations in D-health cancer mortality results
Lancet Diabetes Endocrinol
.
2022 May;10(5):307.
doi: 10.1016/S2213-8587(22)00109-7.
Authors
Sam Egger
1
,
David P Smith
2
,
Visalini Nair-Shalliker
2
Affiliations
1
The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia. Electronic address: samuel.egger@sydney.edu.au.
2
The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia.
PMID:
35461532
DOI:
10.1016/S2213-8587(22)00109-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoplasms* / epidemiology